{
    "clinical_study": {
        "@rank": "13232", 
        "arm_group": [
            {
                "arm_group_label": "High-dose Astragalus group", 
                "arm_group_type": "Active Comparator", 
                "description": "treatment with 10 gram astragalus"
            }, 
            {
                "arm_group_label": "Low-dose Astragalus group", 
                "arm_group_type": "Active Comparator", 
                "description": "treatment with 5 gram astragalus"
            }, 
            {
                "arm_group_label": "MS control", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "Metabolic syndrome have the damages on tissues and organs in heart\u3001kindey and vessels. In\n      this study, prospective randomized, controlled, parallel designed ,different doses of\n      Astragalus Mongolia, Gansu Longxi produce treat on the MS patients, and then use real-time\n      quantitative PCR and Western Blotting to detect the index of oxidative stress\n      \u3001angiotensin-converting enzyme 2 mRNA expression and proteins."
        }, 
        "brief_title": "The Organ Protection of Astragalus in Subjects With Metabolic Syndrome", 
        "condition": "Metabolic Syndrome", 
        "condition_browse": {
            "mesh_term": "Metabolic Syndrome X"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. age 18 years or older, meet the diagnostic criteria of MS\n\n          2. non-allergic with the astragalus\n\n          3. agree to conduct clinical trials and those who signed the informed consent\n\n        Exclusion Criteria:\n\n          1. patients with resistant hypertension\n\n          2. renal disease requiring dialysis\n\n          3. heart failure NYHA \u2162or\u2163;\n\n          4. complications of diabetes\n\n          5. arteritis\n\n          6. cancer\n\n          7. thyroid disease\n\n          8. unstable coronary heart disease\n\n          9. peripheral vascular disease\n\n         10. acute cerebral vascular disease11.pregnancy\u3001 planned pregnancy\n\n         11. patients with anti-oxidants\n\n         12. acute infection\n\n         13. other organic dysfunction, such as the liver, respiratory system, blood system, and\n             other rheumatic diseases."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "420", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01847807", 
            "org_study_id": "MS2304"
        }, 
        "intervention": [
            {
                "arm_group_label": "Low-dose Astragalus group", 
                "intervention_name": "low dose Astragalus", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "High-dose Astragalus group", 
                "intervention_name": "high dose astagalus", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "5-10 gram astragalus per day", 
        "lastchanged_date": "May 6, 2013", 
        "location": {
            "contact": {
                "email": "fengbai@medmail.com", 
                "last_name": "Feng Bai, Doctor", 
                "phone": "+869318942376"
            }, 
            "facility": {
                "address": {
                    "city": "Lanzhou", 
                    "country": "China", 
                    "state": "Gansu", 
                    "zip": "730030"
                }, 
                "name": "Lanzhou University Second Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "3", 
        "official_title": "The Cardiac and Kidney Protection of Astragalus in Subjects With Metabolic Syndrome", 
        "other_outcome": {
            "measure": "kidney function", 
            "safety_issue": "Yes", 
            "time_frame": "one year"
        }, 
        "overall_contact": {
            "email": "wqyconnie@163.com", 
            "last_name": "Qiongying Wang, doctor", 
            "phone": "+869318942076"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "ues echocardiography to measure the cardiac function", 
            "measure": "index of cardiac function", 
            "safety_issue": "Yes", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01847807"
        }, 
        "responsible_party": {
            "investigator_affiliation": "LanZhou University", 
            "investigator_full_name": "Jing Yu", 
            "investigator_title": "cheif of cardiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "blood pressure", 
            "safety_issue": "Yes", 
            "time_frame": "one year"
        }, 
        "source": "LanZhou University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "LanZhou University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}